FIELD: medicine; neurology; psychiatry.
SUBSTANCE: claimed group of inventions relates to the field of medicine, namely neurology and psychiatry, and discloses a pharmaceutical composition for the treatment of a disorder of the central nervous system, containing therapeutically effective amount of a compound of the Formula I, in which: X is -NH-; L is O; Z is -O-; in free or a pharmaceutically acceptable salt form, mixed with a pharmaceutically acceptable diluent or carrier; where the specified disorder of the central nervous system is a disorder related to the substance use, or a disorder caused by the substance use, where the specified disorder related to the substance use, or disorder caused by substance use affects the mu-opioid receptor. The group of inventions also relates to a method for the treatment or prevention of a disorder of the central nervous system.
EFFECT: obtained pharmaceutical compositions are suitable for the treatment of a disorder of the central nervous system, where the specified disorder of the central nervous system is a disorder related to the substance use, or a disorder caused by the substance use, where the specified disorder related to the substance use, or disorder caused by the substance use affects the mu-opioid receptor.
Formula I
14 cl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
ORGANIC COMPOUNDS | 2017 |
|
RU2743513C2 |
ORGANIC COMPOUNDS | 2018 |
|
RU2780002C2 |
ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
ORGANIC COMPOUNDS | 2017 |
|
RU2733975C2 |
ORGANIC COMPOUNDS | 2011 |
|
RU2591194C2 |
ORGANIC COMPOUNDS | 2015 |
|
RU2709786C2 |
COMPOUNDS AND METHODS | 2015 |
|
RU2711442C2 |
ORGANIC COMPOUNDS | 2019 |
|
RU2809023C2 |
ORGANIC COMPOUNDS | 2015 |
|
RU2702732C1 |
ORGANIC COMPOUNDS | 2014 |
|
RU2679142C2 |
Authors
Dates
2022-07-26—Published
2017-01-26—Filed